跳至主要內容

政府暫無計劃推緊急價格管制

商務及經濟發展局局長邱騰華表示,政府目前未有計劃在緊急情況下實行價格管制,或把個別物資種類加至儲備商品名單中。   邱騰華今日在立法會答覆議員吳秋北的提問時說,香港是高度開放的自由港,除非有充分政策考慮而另有規定,所有商品可以自由進出,有效和快速應對市場需求。   由於食米是本港主要食糧,因此在法例上被定為儲備商品。當局一直確保食米供應穩定,並有足夠儲備存貨,以應付緊急或短期供應不足的情況。   邱騰華表示,各政策局和相關部門會繼續審視和留意各重要物資供求情況和市場變化,從而制定適合的措施,以穩定市場供應。   他指,根據第五波疫情等經驗,確保巿場供應充足和穩定,減少供應鏈上的關卡和窒礙,加上有效的資訊發放、與內地政府密切合作、與業界溝通,是有效確保物資供應充足和價格穩定的方法。
http://dlvr.it/SQCns7

此網誌的熱門文章

香港 Backlinks 網站, 中文本地 SEO 必備

市面上的 Backlinks 多數來自外國英文網站,對於香港網站未能精準地改善中文版 Google 排名,有見及此,有 IT 公司推出為香港公司而設的繁體中文 Backlinks 服務,在 100 多個高誠信度的新聞網站刊登文案,增加香港 Backlinks ,大大提升中文版 Google 排名。 新聞網站包括: https://www.buyinghongkong.com https://www.eatinghongkong.com https://www.playinghongkong.com https://www.relaxhongkong.com https://www.hk-bfn.com https://www.hk-cln.com https://www.hk-swn.com https://www.biznews.org.hk https://www.building.org.hk https://www.citylife.org.hk https://www.educate.org.hk https://www.healthy.org.hk https://www.hongkong.org.hk https://www.lohas.org.hk https://www.funding.org.hk https://www.tvp.org.hk https://www.bud.org.hk https://www.smefund.org.hk https://news.business138.com https://news.corporate138.com https://news.company138.com https://news.product138.com https://news.service138.com https://news.solution138.com https://news.website138.com https://news.supplier138.com https://news.vendor138.com https://news.directory138.com https://news.business228.com https:

Hong Kong Science Park: Healthy ecosystem cultivates powerful global collaboration

(English) A healthy ecosystem cultivates powerful global collaboration   BeiGene, a global commercial-stage biotech company, has entered a worldwide strategic collaboration with our park company InnoRNA to take mRNA-based therapeutics to the next level. bit.ly/3yW8S0f You probably heard about Messenger RNA (mRNA). It has been used in some of the leading COVID vaccines. Q: What's mRNA's superpower? A: It directs human cells to generate proteins to help our immune systems develop antibodies for disease prevention and treatment. Q: What's InnoRNA's superpower? A: The platform developed by CEO Dr Li Linxian makes the mRNA less fragile, and the technology can rapidly and accurately identify safe and effective mRNA carriers for clinical treatment. Q: What's HKSTP's superpower? A: Hong Kong is the world's number two biotech funding hub.  We will leave you to find out more! Follow our page for more biotech news in Hong Kong and beyond. Reference : ht

HKSTP Park Company Eurekabio has raised an RMB 100M+ Series B round to advance its automated cell processing platform

Congratulations! Eurekabio has raised an RMB 100M+ Series B round to advance its automated cell processing platform and the lentiviral vector production system developed by their team based at our Park.   Millions of people globally are suffering from different type of cancers. Our park company, Eurekabio, specialises in manufacturing supplies and platform for Cell and Gene Therapies (CGT).   Thank you Eurekabio for playing a pivotal role in accelerating the development of CGT through automation - Standardising cell processing procedures - Increasing efficiency - Reducing human error and contamination   Learn more: https://lnkd.in/gEGmc7Vz   Follow our page for more fundraising news happening in our thriving ecosystem. More Information : https://www.hkstp.org/what-we-offer/institute-for-translational-research-overview/